New Gentleheal® Foam Improves Outcomes, Lowers Costs
Medline Industries (Mundelein, Ill) announces the launch of Gentleheal® Atraumatic Super Absorbent Foam dressings that are designed to help improve patient outcomes, reduce nursing time, and lower costs.
The dressing is easy to use and the silicone-coated surface helps minimize pain during dressing changes. The dressing is absorbent and can stay in place for up to 7 days. Not only does this make it more cost effective than other dressings, it significantly reduces patient discomfort during dressing changes.
Indicated for pressure, arterial, venous, and diabetic leg ulcers, Gentleheal’s waterproof outer film helps to minimize the risk of cross-contamination while providing an ideal moist healing environment. In addition, the dressing’s soft film backing will expand as fluid is absorbed, allowing the dressing to stay secure without pulling on fragile periwound skin. The outer film also allows the clinician to easily monitor wound drainage.
The new dressing contains 2 critically important patent-pending technologies called Exulock® and Sensil®. Inside the dressing, Exulock wicks the exudate vertically where the fluid is “locked” away from the wound. Channels of super-absorbent granules form a hydrogel upon contact with the wound fluid. This process allows more exudate to be absorbed and helps prevent skin maceration allowing the wound to heal. Sensil is a special silicone wound contact layer that gently adheres to the skin around the wound and minimizes the risk of corrosive wound fluid forming between the dressing and the skin.
Visit http://www.medline.com for more information.
Coban™ Compression System Treats Edema Associated with Venous Leg Ulcers 3M (St. Paul, Minn) announces the launch of the Coban™ 2 Layer Compression System, a new wound care product designed to deliver sustained therapeutic compression for the treatment of edema associated with venous leg ulcers and related conditions. The compression system provides a comfortable option for patients and is easy for clinicians to apply.
The system has 2 latex-free roll bandages. The inner layer is a lamination of polyurethane foam that is soft and gentle to the skin. The outer layer is a cohesive bandage designed to provide sustained compression, shown to be effective in the treatment of edema associated with venous leg ulcers. Together, the 2 layers cohere to form a thin, comfortable, effective compression bandage that can help increase patient compliance.
The compression system provides sustained compression for up to 7 days, which ensures therapeutic management of edema to support wound healing.
Call 800-228-3957 for more information.
Advanced BioHealing Announces Purchase of Dermagraft® and TransCyte® Advanced BioHealing, Inc. (ABH, New York, NY) announces the company has concluded the acquisition of the assets and rights to the advanced wound care products Dermagraft® and TransCyte® from Smith & Nephew (Largo, Fla). Both products have been approved for marketing in the United States and other countries. The transaction transfers to ABH the assets and rights relating to these products. Financial terms were not disclosed.
Dermagraft is indicated for use in the treatment of full-thickness diabetic foot ulcers. The product was approved for sale in the United States in 2001. Dermagraft is a cryopreserved human fibroblast-derived dermal substitute. It is supplied frozen in a clear bag containing 1 piece (approximately 2” x 3”) for single-use application.
President and Chief Operating Officer Dr. David Eisenbud founded ABH in 2003 to commercialize an innovative keratinocyte-based healing technology that is enabled by the company’s proprietary cell culture and tissue preservation techniques.
ABH will immediately begin the process of returning the La Jolla, Calif, manufacturing facility to operation, as well as establishing necessary commercial capabilities, including building a sales force. ABH anticipates the facility to be fully functional by the first quarter of 2007.
Visit http://www.AdvancedBioHealing.com for more information.
|
